
主讲人: Dr. Yang Shi, C.H. Waddington Professor of Pediatrics of Harvard Medical School, Professor of Cell Biology at the Department of Cell Biology, Harvard Medical School and Boston Children’s Hospital, USA
主题: Novel Strategies to Treat Cancer Refractory to Immune Checkpoint Bloackade
时间: 11月1日 (周五) 上午9:30-11:00，西湖名师论坛第63期
地点: 西湖大学云栖校区3号楼312会议室
主持人: 西湖大学生命科学学院讲席教授 许田



Sheng, W., LaFleur, M. W., Nguyen, T. H., Chen, S., Chakravarthy, A., Conway, J. R., … Shi, Y. (2018). LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade. Cell, 174(3), 549-563.e19. https://doi.org/10/gdpczm
Result outline for this paper

LSD1 Represses ERV Expression and IFN Activation in Human Cancer Cells
TLR3 and MDA5 Sense dsRNA Accumulation, Caused by LSD1 Abrogation, and Trigger IFN Activation
Decreased Expression of RISC Components Due to Loss of LSD1 Contributes to dsRNA Stress and Promotes IFN Activation
LSD1 Regulates AGO2 Methylation Status and Stability
LSD1 Abrogation-Induced dsRNA Stress Suppresses Tumor Cell Growth In Vitro
LSD1 Abrogation-Induced dsRNA Stress Triggers Anti-tumor T Cell Immunity In Vivo
LSD1 Inhibition Enhances Tumor Immunogenicity and Increases T Cell Infiltration
LSD1 Inhibition Overcomes Tumor Resistance to PD-1 Blockade
Discussion
1. Intracellular dsRNA Homeostasis
2. Tumor Cell-Intrinsic LSD1 Regulates Host Anti-tumor Immunity
3. LSD1 Inhibition and PD-(L)1 Blockade
4.
